TNPH Stock Overview

Develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. More details

TNPH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($425K)

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

Tian'an Pharmaceutical Co., Ltd. Competitors

Altamira Therapeutics

OTCPK:CYTO.F

US$680.3k

AmeriCann

OTCPK:ACAN

US$683.0k

Universe Pharmaceuticals

NasdaqCM:UPC

US$1.0m

Veritas Farms

OTCPK:VFRM

US$163.9k

Price History & Performance

Summary of share price highs, lows and changes for Tian'an Pharmaceutical
Historical stock prices
Current Share Price	US$0.0052
52 Week High	US$0.0066
52 Week Low	US$0.0052
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-21.21%
3 Year Change	n/a
5 Year Change	-84.71%
Change since IPO	-99.45%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	TNPH	US Pharmaceuticals	US Market
7D	0%	-0.6%	-0.2%
1Y	-21.2%	3.0%	25.8%

Return vs Industry: TNPH underperformed the US Pharmaceuticals industry which returned 3% over the past year.

Return vs Market: TNPH underperformed the US Market which returned 25.8% over the past year.

Price Volatility

Is TNPH's price volatile compared to industry and market?
TNPH volatility
TNPH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.8%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: TNPH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine TNPH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2003	n/a	Jianjun Weng	n/a

Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company’s pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels.

Tian'an Pharmaceutical Co., Ltd. Fundamentals Summary

How do Tian'an Pharmaceutical's earnings and revenue compare to its market cap?
TNPH fundamental statistics
Market cap	US$424.97k
Earnings (TTM)	US$3.14m
Revenue (TTM)	US$10.65m

0.0x

P/E Ratio

0.0x

P/S Ratio

Is TNPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TNPH income statement (TTM)
Revenue	US$10.65m
Cost of Revenue	US$3.35m
Gross Profit	US$7.30m
Other Expenses	US$4.16m
Earnings	US$3.14m

Last Reported Earnings

Dec 31, 2007

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did TNPH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/05 07:10
End of Day Share Price	2024/10/09 00:00
Earnings	2007/12/31
Annual Earnings	2007/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tian'an Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution